Work

Supplementary Figure 1 from Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 50K, Correlation between βIII-tubulin IHC (Saura et al. manuscript in preparation) and mRNA expression data. *Median cut-off used to determine high versus low βIII-tubulin mRNA expression. IHC, immunohistochemistry.

DOI: 10.1158/1078-0432.22450695

Authors: Christine E. Horak, Lajos Pusztai, Guan Xing, Ovidiu C. Trifan, Cristina Saura, Ling-Ming Tseng, Stephen Chan, Rosanne Welcher, David Liu

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361910076

Cites:

Cited by:

Related to: 10